Belgium vs Paraguay: HIV/AIDS deaths averted by antiretroviral therapy
Belgium
636.61 deaths
in 2024
Paraguay
748.25 deaths
in 2024
Belgium rank
85th
Paraguay rank
82nd
HIV/AIDS deaths averted by antiretroviral therapy over time
- Belgium
- Paraguay
How they compare
Paraguay currently reports 748.25 deaths against 636.61 deaths in Belgium, a difference of 111.64 deaths.
That makes Paraguay's figure about 1.2 times Belgium's.
The two have swapped places 2 times across 35 shared years of data; in 1990 it was Paraguay ahead.
Belgium ranks 85th and Paraguay ranks 82nd of 157 countries.
Across the 4 decades both report, Belgium averaged higher in 3 and Paraguay in 1.
Head to head by decade
| Decade | Belgium | Paraguay | Difference | Ahead |
|---|---|---|---|---|
| 1990s | 99.54 deaths | 0 deaths | 99.54 deaths | Belgium |
| 2000s | 355.19 deaths | 104.86 deaths | 250.34 deaths | Belgium |
| 2010s | 595.22 deaths | 475.81 deaths | 119.41 deaths | Belgium |
| 2020s | 650.64 deaths | 692.4 deaths | 41.77 deaths | Paraguay |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hiv/aids deaths averted by antiretroviral therapy, Belgium or Paraguay?
- Paraguay, at 748.25 deaths against 636.61 deaths in Belgium as of 2024.
- What is the difference in hiv/aids deaths averted by antiretroviral therapy between Belgium and Paraguay?
- 111.64 deaths, with Paraguay ahead.
- How many years of comparable data are there for Belgium and Paraguay?
- 35 years are reported by both, from 1990 to 2024.
- How do Belgium and Paraguay rank globally for hiv/aids deaths averted by antiretroviral therapy?
- Belgium ranks 85th and Paraguay ranks 82nd of 157 countries.
- Where does this data come from?
- Joint United Nations Programme on HIV/AIDS (2026) – with minor processing by Our World in Data, published as HIV/AIDS deaths averted by antiretroviral therapy. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of deaths prevented as a direct result of Antiretroviral Therapy (ART) among people living with HIV. It is calculated by comparing the observed mortality rates in individuals receiving ART to the estimated mortality rates in the absence of such treatment. This is the central estimate.